Literature DB >> 6966002

Pretreatment, prediagnosis immunoglobulin, and alpha 1-antitrypsin levels in patients with bronchial carcinoma.

D R Nash, J W McLarty, N G Fortson.   

Abstract

Sera from 148 patients suspected of having bronchial carcinoma were evaluated for concentrations of IgA, IgM, IgG, and alpha 1-antitrypsin (alpha 1-AT). Histologically, 137 tumor specimens obtained by bronchoscopy or surgical biopsy were diagnosed as squamous cell carcinoma (55%), adenocarcinoma (18%), undifferentiated small cell carcinoma (20%), or undifferentiated large cell carcinoma (7%). The tumor types of the remaining 11 patients were not identifiable from the records but were included as a separate group. Serum protein values were compared with those of a control group of 60 healthy adult volunteers. Regression analysis of age, race, and sex effects on the results of comparisons between test and control groups indicated that, with the possible exception of age and IgM, these three independent variables did not significantly influence the observations. Both serum IgA and alpha 1-AT were significantly elevated in all tumor groups when compared to the control levels. This was not the situation for serum IgG. Results for serum IgM were equivocal and depended on the statistical methods used. Although the serum immunoglobulin concentrations for the small cell carcinoma group were consistently lower than those for the other tumor cell types, no statistically significant difference existed between the five tumor groups in this regard.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6966002

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  3 in total

1.  C1q binding activity in the sera of patients with chronic lung diseases.

Authors:  K M Cooper; M Moore; A M Hilton
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

2.  Identification of Potential Glycoprotein Biomarkers in Estrogen Receptor Positive (ER+) and Negative (ER-) Human Breast Cancer Tissues by LC-LTQ/FT-ICR Mass Spectrometry.

Authors:  Suzan M Semaan; Xu Wang; Alan G Marshall; Qing-Xiang Amy Sang
Journal:  J Cancer       Date:  2012-06-21       Impact factor: 4.207

3.  alpha1-antitrypsin and its C-terminal fragment attenuate effects of degranulated neutrophil-conditioned medium on lung cancer HCC cells, in vitro.

Authors:  Inga Zelvyte; Tim Stevens; Ulla Westin; Sabina Janciauskiene
Journal:  Cancer Cell Int       Date:  2004-11-21       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.